F.D.A. Approves Moderna’s mRNA Flu Vaccine
The FDA has approved the first mRNA flu vaccine, Moderna's mFlusiva, for older adults.
Evidence dossier
Intelligence passport
Measured timeline
- Detected The first matching coverage entered the Archynetys cluster.
- Evidence threshold reached The story had enough independent coverage for an explanatory brief.
- Peak measured velocity The recorded velocity reached 12.
- Latest coverage observed Most recent article currently attached to this story cluster.
Source diversity sample: STAT · WSJ · time.com · The Guardian · kcci.com · ABC7 New York · Fierce Pharma · Forbes.
How this dossier is built: methodology · AI policy · corrections.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Food and Drug Administration approved Moderna's mRNA seasonal flu vaccine, mFlusiva. The approval follows a refusal-to-file issue that delayed the process. The vaccine is specifically approved for older adults.
ABC7 New York and Reuters both confirm the approval. Forbes specifies the age group. Fierce Pharma provides the most detail on the regulatory process.
The approval process and the specific benefits of mFlusiva for older adults are not yet clear. The vaccine's rollout and public reception are also unknown.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (89% supported) Updated 5h ago.
The reporting (12)
- One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was STAT · 9h ago
- Moderna Stock Rises After mRNA Flu Shot Approval WSJ · 9h ago
- FDA Approves the First mRNA Flu Vaccine time.com · 9h ago
- The mRNA technology behind Moderna’s Covid vaccine reaches the flu The Guardian · 9h ago
- FDA approves first mRNA-based flu vaccine kcci.com · 10h ago
- FDA approves Moderna's mRNA seasonal flu vaccine ABC7 New York · 10h ago
- Moderna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio Fierce Pharma · 10h ago
- FDA Approves First MRNA Flu Vaccine For Older Adults Forbes · 10h ago
- FDA approves Moderna's mRNA seasonal flu vaccine ABC News - Breaking News, Latest News and Videos · 11h ago
- New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine AP News · 12h ago
- FDA approves Moderna's mRNA flu vaccine after initial pushback CBS News · 12h ago
- US FDA approves first mRNA flu shot from Moderna Reuters · 13h ago
Quick answers
What is the name of the approved vaccine?
The approved vaccine is called mFlusiva.
Who is the vaccine approved for?
The vaccine is approved for older adults.
Which company developed the vaccine?
The vaccine was developed by Moderna.
Topics
Related trends
FDA approves 1st mRNA flu shot, from Moderna
The FDA has approved the first mRNA flu vaccine, marking a significant shift in flu shot technology.
CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases
CVS Health's new GLP-1 partnership with Eli Lilly is reshaping weight management services and boosting profits.
Nicotine pouches can be marketed as 'lower risk' than cigarettes. Is that dangerous?
The FDA has authorized new nicotine pouches, sparking debate on their safety and marketing.
Autism spectrum disorder: has it lost its meaning and is it leading to misdiagnosis?
Experts question whether the autism spectrum disorder definition is too broad, potentially leading to misdiagnosis.
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna's new Ebola vaccine trial could be a game-changer for the DRC outbreak, but the race is on against time
Pancreatic cancer drug now available in Cleveland offers new hope
A new pancreatic cancer drug is now available in Cleveland, offering renewed hope to patients.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.